Recon Sports Medicine Study shows patients treated with Smith+Nephew’s CARTIHEAL™ AGILI-C™ Cartilage Repair Implant have an 87% lower relative risk of Total Knee Arthroplasty or Osteotomy at 4 years¹* byJosh SandbergMay 7, 2025
Financial Sports Medicine Smith+Nephew completes acquisition of novel cartilage regeneration technology for sports medicine knee repair byJosh SandbergJanuary 10, 2024
Biologics Financial Sports Medicine Top Stories Smith+Nephew acquires novel cartilage regeneration technology for sports medicine knee repair byJosh SandbergNovember 22, 2023
Sports Medicine CartiHeal Announces First Commercial Implantation of Agili-C™ in the US byJosh SandbergJuly 26, 2023
Financial Top Stories Bioventus Exercises Call Option to Acquire CartiHeal byChris StewartApril 4, 2022
Extremities Regulatory Top Stories FDA approves CartiHeal’s Implant for the Treatment of Cartilage and Osteochondral Defects byJosh SandbergMarch 30, 2022
Extremities Sports Medicine CartiHeal Announces Pivotal Study Results Demonstrate Agili-C™ Superiority to Microfracture and Debridement for the Treatment of Cartilage and Osteochondral Defects byChris StewartAugust 3, 2021
Regulatory Sports Medicine CartiHeal Receives FDA “Breakthrough Device Designation” for the novel Agili-C Implant byChris StewartOctober 12, 2020
